Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002528.SZ Stock Summary
Top 10 Correlated ETFs
002528.SZ
In the News
002528.SZ Financial details
Company Rating
Sell
Market Cap
7.48B
Income
-1.23B
Revenue
1.53B
Book val./share
0.74
Cash/share
0.23
Dividend
-
Dividend %
-
Employees
832
Optionable
No
Shortable
Yes
Earnings
20 Apr 2024
P/E
-6.84
Forward P/E
-
PEG
4.93
P/S
5.75
P/B
9.52
P/C
23.83
P/FCF
-9.33
Quick Ratio
0.85
Current Ratio
1.24
Debt / Equity
1.02
LT Debt / Equity
0.48
-
-
EPS (TTM)
-1.03
EPS next Y
-
EPS next Q
-
EPS this Y
-23.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-15.52%
Revenue Q/Q
5.89%
EPS Q/Q
437.38%
-
-
-
-
SMA20
-17.91%
SMA50
-12.35%
SMA100
-30.54%
Inst Own
-
Inst Trans
-
ROA
-37%
ROE
-110%
ROC
-0.88%
Gross Margin
14%
Oper. Margin
-78%
Profit Margin
-81%
Payout
-5%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.11-11.09
52W High
-50.18%
52W Low
+9.6%
RSI
31.88
Rel Volume
0.29
Avg Volume
31.21M
Volume
8.95M
Perf Week
-13.43%
Perf Month
-22.71%
Perf Quarter
-32.51%
Perf Half Y
-37.51%
-
-
-
-
Beta
-0.039
-
-
Volatility
0.34%, 0.59%
Prev Close
-2.49%
Price
5.48
Change
-5.19%
002528.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.81 | 3.96 | 4.37 | 2.45 | 1.53 | |
Net income per share | 0.12 | 0.06 | 0.07 | -1.2 | -0.92 | |
Operating cash flow per share | -0.26 | -0.69 | -0.48 | 0.1 | -0.07 | |
Free cash flow per share | -0.31 | -0.72 | -0.55 | 0.06 | -0.15 | |
Cash per share | 0.58 | 0.71 | 0.5 | 0.11 | 0.71 | |
Book value per share | 3.26 | 3.15 | 3.17 | 1.94 | 1.04 | |
Tangible book value per share | 2.22 | 2.11 | 2.13 | 1.83 | 0.94 | |
Share holders equity per share | 3.26 | 3.15 | 3.17 | 1.94 | 1.04 | |
Interest debt per share | 0.64 | 0.99 | 1.44 | 1.36 | 1.34 | |
Market cap | 4.08B | 6.31B | 4.18B | 4.46B | 13.45B | |
Enterprise value | 4.11B | 6.67B | 5.28B | 4.82B | 14.48B | |
P/E ratio | 29.43 | 84.03 | 47.81 | -3.1 | -12.14 | |
Price to sales ratio | 0.96 | 1.33 | 0.8 | 1.52 | 7.32 | |
POCF ratio | -13.8 | -7.6 | -7.32 | 37.62 | -158.27 | |
PFCF ratio | -11.77 | -7.32 | -6.34 | 64.4 | -76.78 | |
P/B Ratio | 1.12 | 1.67 | 1.1 | 1.92 | 10.75 | |
PTB ratio | 1.12 | 1.67 | 1.1 | 1.92 | 10.75 | |
EV to sales | 0.96 | 1.4 | 1.01 | 1.64 | 7.88 | |
Enterprise value over EBITDA | 13.43 | 24.98 | 14.21 | -63.12 | -65.33 | |
EV to operating cash flow | -13.89 | -8.03 | -9.25 | 40.68 | -170.41 | |
EV to free cash flow | -11.85 | -7.73 | -8.01 | 69.64 | -82.66 | |
Earnings yield | 0.03 | 0.01 | 0.02 | -0.32 | -0.08 | |
Free cash flow yield | -0.08 | -0.14 | -0.16 | 0.02 | -0.01 | |
Debt to equity | 0.19 | 0.3 | 0.44 | 0.66 | 1.22 | |
Debt to assets | 0.12 | 0.17 | 0.21 | 0.25 | 0.34 | |
Net debt to EBITDA | 0.09 | 1.34 | 2.96 | -4.75 | -4.65 | |
Current ratio | 2.09 | 1.67 | 1.37 | 1.36 | 1.2 | |
Interest coverage | 7.34 | 4.28 | 4.61 | -3.83 | -3.81 | |
Income quality | -2.12 | -11.35 | -6.98 | -0.08 | 0.08 | |
Dividend Yield | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
Payout ratio | 0.27 | 0.67 | 0.79 | -0.05 | -0.07 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.04 | 0.04 | |
Research and developement to revenue | 0.04 | 0.04 | 0.04 | 0.07 | 0.06 | |
Intangibles to total assets | 0.22 | 0.19 | 0.16 | 0.02 | 0.02 | |
Capex to operating cash flow | 0.17 | 0.04 | 0.15 | -0.42 | 1.06 | |
Capex to revenue | -0.01 | -0.01 | -0.02 | -0.02 | -0.05 | |
Capex to depreciation | -1.28 | -0.74 | -1.54 | -0.54 | -1.49 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | -0.02 | -0.02 | |
Graham number | 3.01 | 2.11 | 2.28 | 7.25 | 4.66 | |
ROIC | 0.06 | 0.04 | 0.04 | -0.08 | -0.11 | |
Return on tangible assets | 0.03 | 0.01 | 0.01 | -0.24 | -0.25 | |
Graham Net | 0.27 | 0.03 | -0.73 | -1.45 | -0.8 | |
Working capital | 1.82B | 1.57B | 1.21B | 1.15B | 586.81M | |
Tangible asset value | 2.49B | 2.53B | 2.55B | 2.2B | 1.13B | |
Net current asset value | 1.71B | 1.15B | 529.62M | 635.25M | 308.31M | |
Invested capital | 0.19 | 0.3 | 0.44 | 0.66 | 1.22 | |
Average receivables | 1.36B | 1.87B | 2.51B | 2.51B | 1.92B | |
Average payables | 458.17M | 763.05M | 1.18B | 1.46B | 1.34B | |
Average inventory | 461.98M | 555.98M | 628.46M | 592.54M | 443.36M | |
Days sales outstanding | 134.86 | 166.58 | 198.39 | 269.17 | 331.7 | |
Days payables outstanding | 65.26 | 91.07 | 125.75 | 235.77 | 262.16 | |
Days of inventory on hand | 55.82 | 59.05 | 57.58 | 83.88 | 78.88 | |
Receivables turnover | 2.71 | 2.19 | 1.84 | 1.36 | 1.1 | |
Payables turnover | 5.59 | 4.01 | 2.9 | 1.55 | 1.39 | |
Inventory turnover | 6.54 | 6.18 | 6.34 | 4.35 | 4.63 | |
ROE | 0.04 | 0.02 | 0.02 | -0.62 | -0.89 | |
Capex per share | -0.05 | -0.03 | -0.07 | -0.04 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.39 | 0.45 | 0.28 | 0.26 | 0.28 | |
Net income per share | -0.1 | -0.72 | -0.04 | -0.04 | -0.23 | |
Operating cash flow per share | -0.1 | -0.72 | -0.04 | 0.02 | 0.05 | |
Free cash flow per share | -0.11 | -0.74 | -0.05 | -0.02 | 0.03 | |
Cash per share | 0.84 | 0.71 | 0.69 | 0.46 | 0.23 | |
Book value per share | 1.76 | 1.04 | 1 | 0.97 | 0.74 | |
Tangible book value per share | 1.65 | 0.94 | 0.91 | 0.87 | 0.65 | |
Share holders equity per share | 1.76 | 1.04 | 1 | 0.97 | 0.74 | |
Interest debt per share | 1.35 | 1.29 | 1.19 | 0.99 | 0.76 | |
Market cap | 3.78B | 13.45B | 14.66B | 9.71B | 10.58B | |
Enterprise value | 4.95B | 14.48B | 15.64B | 10.42B | 11.22B | |
P/E ratio | -8.03 | -3.91 | -75.32 | -47.26 | -9.63 | |
Price to sales ratio | 8.08 | 24.84 | 43.2 | 30.87 | 31.78 | |
POCF ratio | -32.12 | -15.64 | -301.28 | 493.69 | 171.66 | |
PFCF ratio | -28.44 | -15.12 | -229.16 | -437.52 | 321.24 | |
P/B Ratio | 1.79 | 10.75 | 12.2 | 8.35 | 11.94 | |
PTB ratio | 1.79 | 10.75 | 12.2 | 8.35 | 11.94 | |
EV to sales | 10.57 | 26.75 | 46.09 | 33.14 | 33.68 | |
Enterprise value over EBITDA | -103.61 | -108.06 | -360.29 | -221.76 | -340.91 | |
EV to operating cash flow | -42.06 | -16.84 | -321.49 | 529.95 | 181.96 | |
EV to free cash flow | -37.24 | -16.28 | -244.52 | -469.67 | 340.5 | |
Earnings yield | -0.03 | -0.06 | 0 | -0.01 | -0.03 | |
Free cash flow yield | -0.04 | -0.07 | 0 | 0 | 0 | |
Debt to equity | 0.76 | 1.22 | 1.17 | 1.01 | 1.02 | |
Debt to assets | 0.28 | 0.34 | 0.33 | 0.3 | 0.27 | |
Net debt to EBITDA | -24.48 | -7.69 | -22.64 | -15.18 | -19.29 | |
Current ratio | 1.41 | 1.2 | 1.19 | 1.19 | 1.24 | |
Interest coverage | -3.12 | -45.42 | -2.53 | -3.97 | -26.32 | |
Income quality | 1 | 1 | 1 | -0.38 | -0.22 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.22 | -0.02 | -0.45 | -0.07 | -0.07 | |
Sales general and administrative to revenue | 0.27 | -0.15 | 0.15 | -0.08 | 0.37 | |
Research and developement to revenue | 0.06 | 0.05 | 0.07 | 0.07 | 0.08 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Capex to operating cash flow | 0.13 | 0.03 | 0.31 | -2.13 | -0.47 | |
Capex to revenue | -0.03 | -0.05 | -0.05 | -0.13 | -0.09 | |
Capex to depreciation | -0.98 | -1.9 | -1.32 | -3.6 | 1.15 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.97 | 4.1 | 0.96 | 0.97 | 1.95 | |
ROIC | -0.02 | -0.31 | -0.02 | -0.02 | -0.15 | |
Return on tangible assets | -0.02 | -0.2 | -0.01 | -0.01 | -0.09 | |
Graham Net | -0.65 | -0.8 | -0.79 | -0.81 | -0.81 | |
Working capital | 1.15B | 586.81M | 536.59M | 480.42M | 475.55M | |
Tangible asset value | 1.98B | 1.13B | 1.09B | 1.05B | 774.31M | |
Net current asset value | 411.27M | 308.31M | 265.09M | 173.74M | 631.93K | |
Invested capital | 0.76 | 1.22 | 1.17 | 1.01 | 1.02 | |
Average receivables | 1.94B | 1.83B | 1.63B | 1.54B | 1.44B | |
Average payables | 1.36B | 1.26B | 1.14B | 1.06B | 976.75M | |
Average inventory | 501.23M | 433.62M | 346.24M | 340.13M | 318.22M | |
Days sales outstanding | 383.83 | 277.6 | 422.42 | 426.39 | 373.75 | |
Days payables outstanding | 295.65 | 207.57 | 354.6 | 346.17 | 316.03 | |
Days of inventory on hand | 112.98 | 62.46 | 108.63 | 116.61 | 99.21 | |
Receivables turnover | 0.23 | 0.32 | 0.21 | 0.21 | 0.24 | |
Payables turnover | 0.3 | 0.43 | 0.25 | 0.26 | 0.28 | |
Inventory turnover | 0.8 | 1.44 | 0.83 | 0.77 | 0.91 | |
ROE | -0.06 | -0.69 | -0.04 | -0.04 | -0.31 | |
Capex per share | -0.01 | -0.02 | -0.01 | -0.03 | -0.02 |
002528.SZ Frequently Asked Questions
What is Shenzhen Infinova Limited stock symbol ?
Shenzhen Infinova Limited is a CN stock and trading under the symbol 002528.SZ
What is Shenzhen Infinova Limited stock quote today ?
Shenzhen Infinova Limited stock price is $5.48 today.
Is Shenzhen Infinova Limited stock public?
Yes, Shenzhen Infinova Limited is a publicly traded company.